2 studies found for:    Trinity Chicago IL | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
2 Recruiting Effects of the Probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers
Condition: HIV-1 Infection
Interventions: Drug: Visibiome;   Drug: Placebo

Indicates status has not been verified in more than two years